Skip to main content
 
Friday, October 6, 2017

In the latest installment of our special series “Innovation Happens,” we take a look at CIMAvax, a promising lung cancer vaccine developed in Cuba that is getting a lot of attention here in the United States. It is being studied in an FDA approved clinical trial at Roswell Park Cancer Institute-- the first Cuban therapy to be tested in the US. Our guest is Dr. Mary Reid, the Director of Cancer Screening and Survivorship at Roswell Park and a key member of the team that is collaborating with Cuban scientists on CIMAvax. Dr. Reid shares with us the history of the vaccine and how it could spur a new age of American-Cuban medical collaboration.